For the readers interested in the stock health of Acutus Medical Inc. (AFIB). It is currently valued at $28.50. When the transactions were called off in the previous session, Stock hit the highs of $30.18, after setting-off with the price of $30.14. Company’s stock value dipped to $27.00 during the trading on the day. When the trading was stopped its value was $34.00.
Recently in News on January 13, 2021, Acutus Medical Reports Preliminary, Unaudited Fourth Quarter and Full Year 2020 Results. Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited revenue results for the quarter and full year ended December 31, 2020. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Acutus Medical Inc. shares are logging -26.89% during the 52-week period from high price, and 28.05% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $22.26 and $38.99.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1271455 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Acutus Medical Inc. (AFIB) recorded performance in the market was -1.06%, having the revenues showcasing 2.24% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 801.85M, as it employees total of 224 workers.
The Analysts eye on Acutus Medical Inc. (AFIB)
During the last month, 0 analysts gave the Acutus Medical Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 28.87, with a change in the price was noted +1.43. In a similar fashion, Acutus Medical Inc. posted a movement of +5.30% for the period of last 100 days, recording 174,590 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AFIB is recording 0.30 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.28.
Technical rundown of Acutus Medical Inc. (AFIB)
Raw Stochastic average of Acutus Medical Inc. in the period of last 50 days is set at 51.65%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 20.48%. In the last 20 days, the company’s Stochastic %K was 70.19% and its Stochastic %D was recorded 81.97%.
Considering, the past performance of Acutus Medical Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -1.06%. The shares increased approximately by -12.18% in the 7-day charts and went down by -4.12% in the period of the last 30 days. Common stock shares were driven by 2.24% during last recorded quarter.